Collaborative, Multisectoral, and Multidisciplinary Approach to Enhance FDA One Health Initiative Communication Strategies

Author(s)

Pampell M1, Okoye G2, Rupak S3, Resnik P3, Mullins CD2, Rogers P4, Araojo R1, Lee C1
1U.S. FDA, White Oak, MD, USA, 2University of Maryland School of Pharmacy, Baltimore, MD, USA, 3University of Maryland, College Park, College Park, MD, USA, 4U.S. FDA, Jefferson, AR, USA

Presentation Documents

OBJECTIVES:

The One Health Approach (OHA) involves a collaborative, multisectoral, multidisciplinary framework to address public health challenges and achieve optimal health outcomes. OHA recognizes the interconnection between people, animals, plants, and their shared environment. This M-CERSI project amplifies the OHA by amplifying and synergizing different disciplines (e.g., social, and behavioral sciences, machine learning, and artificial intelligence options) with expertise from various FDA centers, offices, and academia to harness narrative COVID-19 unstructured publicly available data.

METHODS:

Human curation and machine learning techniques are augmented with social and behavioral science methods and input by subject matter experts, across four sequential components. First, the collection of publicly available data from various FDA input and output sources. Second, the systematic narrowing of scope of inclusion to public comments submitted to Regulations.gov in response to COVID-19 related meetings and dockets. Third, the extraction of approximately 140,000 comments using computing methods and the newly available OpenGSA Application Programming Interface (API). Fourth, preprocessing and analysis to generate insights using a machine learning technique, topic modeling, combined with human curation techniques.

RESULTS:

Results included the determination of a structure whereby public comment groupings can be parsed into meaningful subsets. Integrative analysis via human curation and computing methods yielded insights into public opinion as well as producing machine learning models that may be applied to future datasets. These results highlight the value of building a multidisciplinary OHA framework.

CONCLUSIONS:

This multidisciplinary research collaboration supports FDA’s regulatory public health mission and the OHA, effectively reducing silos and leveraging expertise across the scientific spectrum. This approach can be implemented to provide ongoing, timely and accurate information across stakeholder groups. The next phase of research will apply discovered insights to design focus group sample populations, contrast emerging themes, and develop clear messaging that is responsive to public interests and concerns.

Conference/Value in Health Info

2022-11, ISPOR Europe 2022, Vienna, Austria

Value in Health, Volume 25, Issue 12S (December 2022)

Code

MSR72

Topic

Epidemiology & Public Health, Methodological & Statistical Research, Patient-Centered Research

Topic Subcategory

Artificial Intelligence, Machine Learning, Predictive Analytics, Patient Behavior and Incentives, PRO & Related Methods, Public Health

Disease

STA: Drugs, STA: Medical Devices, STA: Nutrition, STA: Veterinary Medicine

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×